|
| The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis |
|
https://doi.org/10.18632/oncotarget.28038
Nivaldo Faria Vieira, Luciano Neder Serafini, Paulo Cezar Novais, Fermino Sanches Lizarte Neto, Mucio Luiz de Assis Cirino, Rafael Kemp, José Celso Ardengh, Fabiano Pinto Saggioro, Alberto Facury Gaspar, Ajith Kumar Sankarankutty, Jorge Resende Lopes Júnior, Daniela Pretti da Cunha Tirapelli, José Sebastião dos Santos
|
| 1638-1650 |
|
| Diverse transcriptional regulation and functional effects revealed by CRISPR/Cas9-directed epigenetic editing |
|
https://doi.org/10.18632/oncotarget.28037
Miguel Vizoso, Jacco van Rheenen
|
| 1651-1662 |
|
| The protective role of prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion |
|
https://doi.org/10.18632/oncotarget.28041
Giovanna Casili, Sarah Adriana Scuderi, Marika Lanza, Alessia Filippone, Rossella Basilotta, Deborah Mannino, Michela Campolo, Emanuela Esposito, Irene Paterniti
|
| 1663-1676 |
|
| Quantitative difference of oral pathogen between individuals with gastric cancer and individuals without cancer |
|
https://doi.org/10.18632/oncotarget.28034
Gyselle Ribeiro de Carvalho Oliveira, Carla de Castro Sant’ Anna, Letícia Martins Lamarão, Adriana Costa Guimarães, Carlos Machado da Rocha, Marcelo de Oliveira Bahia, Carolina Rosal de Souza, Danielle Queiroz Calcagno, Paulo Pimentel de Assumpção, Rommel Rodriguez Burbano
|
| 1677-1686 |
|
| Scent test using Caenorhabditis elegans to screen for early-stage pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.28035
Ayumu Asai, Masamitsu Konno, Miyuki Ozaki, Koichi Kawamoto, Ryota Chijimatsu, Nobuaki Kondo, Takaaki Hirotsu, Hideshi Ishii
|
| 1687-1696 |
|
| Exosomal and non-exosomal miRNA expression levels in patients with HCV-related cirrhosis and liver cancer |
|
https://doi.org/10.18632/oncotarget.28036
Alisa A. Petkevich, Aleksandr A. Abramov, Vadim I. Pospelov, Natalya A. Malinina, Elena I. Kuhareva, Natalya V. Mazurchik, Olga I. Tarasova
|
| 1697-1706 |
|
| Role of microRNAs in glioblastoma |
|
https://doi.org/10.18632/oncotarget.28039
Ming Chen, Zdravka Medarova, Anna Moore
|
| 1707-1723 |
|
| Mantle cell lymphoma patients in first relapse: we pretty much know what to do |
|
https://doi.org/10.18632/oncotarget.27980
Francesca Maria Quaglia, Carlo Visco
|
| 1724-1726 |
|
| UBE2T: A new molecular regulator of cancer stemness in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.28033
Rainbow Wing Hei Leung, Nicole Pui Yu Ho, Carmen Oi Ning Leung, Terence Kin Wah Lee
|
| 1727-1728 |
|
| Hypofractionation: less is more? |
|
https://doi.org/10.18632/oncotarget.28023
Neethu Billy Graham Mariam, Yee Pei Song, Nuradh Joseph, Peter Hoskin, Kimberley Reeves, Nuria Porta, Nicholas James, Ananya Choudhury
|
| 1729-1733 |
|
| Correction: Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach |
|
https://doi.org/10.18632/oncotarget.28050
Zhiguang Xiao, Bianca Sperl, Silvia Gärtner, Tatiana Nedelko, Elvira Stacher-Priehse, Axel Ullrich, Pjotr G. Knyazev
|
| 1734-1735 |
|
| Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer |
|
https://doi.org/10.18632/oncotarget.28051
Teru Hideshima, Ralph Mazitschek, Jun Qi, Naoya Mimura, Jen-Chieh Tseng, Andrew L. Kung, James E. Bradner, Kenneth C. Anderson
|
| 1736-1736 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
